SCHEMBL21036231

SCHEMBL21036231

NC1CC2CCC(C1)N2C(=O)[C@@H]1CN(Cc2ccc(-c3ccc(Cl)cc3)cc2)CCN1S(=O)(=O)c1ccc2cc(OC3CCCC3)ccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.40
GHSR Q92847 4/20 0.39
HTR1A P08908 2/20 0.39
HTR7 P34969 2/20 0.39
HTR5A P47898 2/20 0.39
HTR1D P28221 1/20 0.39
HTR1B P28222 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
ADRA1A P35348 1/20 0.39
HTR2B P41595 1/20 0.39
HTR6 P50406 1/20 0.39
HTR4 Q13639 1/20 0.39
MMP1 P03956 3/20 0.38
MMP9 P14780 2/20 0.38
MMP13 P45452 2/20 0.38
MMP3 P08254 1/20 0.38
MMP7 P09237 1/20 0.38
CCR4 P51679 3/20 0.38
KCNH2 Q12809 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21036187 1.00 CHEK2 (0.40) CHEK2GHSRHTR1AHTR7HTR5A
SCHEMBL21035094 1.00 CHEK2 (0.40) CHEK2GHSRHTR1AHTR7HTR5A
Trifluoroacetic Acid SCHEMBL21002039 0.95 MMP1 (0.37) CHEK2GHSRHTR1AHTR7HTR5A
Trifluoroacetic Acid SCHEMBL21002157 0.95 MMP1 (0.37) CHEK2GHSRHTR1AHTR7HTR5A
SCHEMBL21034969 0.90 ADRB2 (0.40) MMP1MMP9MMP13MMP3MMP7
SCHEMBL21035344 0.90 GHSR (0.46) CHEK2GHSRHTR1AHTR7HTR5A
SCHEMBL21035071 0.90 GHSR (0.46) CHEK2GHSRHTR1AHTR7HTR5A
SCHEMBL21035331 0.90 GHSR (0.46) CHEK2GHSRHTR1AHTR7HTR5A
SCHEMBL21035133 0.86 HTR1A (0.41) GHSRHTR1AHTR7HTR5AHTR1D
SCHEMBL21035004 0.86 HTR1A (0.41) GHSRHTR1AHTR7HTR5AHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed